ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of
coronary artery disease and is associated with great morbidity and mortality. A complete …

The no-reflow phenomenon refers to the observation that when an organ is made ischemic
by occlusion of a large artery supplying it, restoration of patency in that artery does not …

The prevalence of heart failure (HF) due to cardiac remodelling after acute myocardial
infarction (AMI) does not decrease regardless of implementation of new technologies …

Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …

Myocardial infarction (MI) is the leading cause of death worldwide and can lead to the loss of
cardiac function and heart failure. Reactive oxygen species (ROS) play a key role in the …

Background Platelet‐to‐lymphocyte ratio (PLR) is a haematological index which reflects
increased level of inflammation and thrombosis. We aimed to summarize the potential …

There is a lack of understanding in the cardiac remodeling field regarding the use of
nonreperfused myocardial infarction (MI) and reperfused MI in animal models of MI. This …

Complications of percutaneous coronary intervention (PCI) may have significant impact on
patient survival and healthcare costs. PCI procedural complexity and patient risk are …

Successful reperfusion of an infarct-related coronary artery by primary percutaneous
intervention or fibrinolysis during acute ST-elevation myocardial infarction (STEMI) does not …

Ischemic heart disease (IHD) has several risk factors, among which diabetes mellitus
represents one of the most important. In diabetic patients, the pathophysiology of myocardial …